Literature DB >> 1793515

Protein C degradation in vitro by neutrophil elastase.

I Eckle1, R Seitz, R Egbring, G Kolb, K Havemann.   

Abstract

Purified protein C is completely degraded into small peptides by in vitro incubation with purified elastase. Protein C is a rather sensitive substrate as degradation is already accomplished by low elastase concentrations (molar enzyme-to-substrate ratio 1:510) and short incubation periods (5 min-60 min). Protein C in a PPSB coagulation factor concentrate is equally degraded and similar split products are detected by blotting techniques. The protein C activity (measured by a chromogenic substrate) is faster reduced by elastase than the protein C concentration (measured by an ELISA). Incubation of normal plasma with high elastase concentrations (5.7 nmol/ml plasma) results in reduction of the protein C band while no split products are detectable. The pathophysiologic significance of the effects of elastase on protein C remains to be elucidated.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1793515     DOI: 10.1515/bchm3.1991.372.2.1007

Source DB:  PubMed          Journal:  Biol Chem Hoppe Seyler        ISSN: 0177-3593


  11 in total

1.  Metformin attenuates hyperoxia-induced lung injury in neonatal rats by reducing the inflammatory response.

Authors:  Xueyu Chen; Frans J Walther; Rozemarijn M A Sengers; El Houari Laghmani; Asma Salam; Gert Folkerts; Tonio Pera; Gerry T M Wagenaar
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-06-05       Impact factor: 5.464

Review 2.  Pathogenesis and pathophysiology of pneumococcal meningitis.

Authors:  Barry B Mook-Kanamori; Madelijn Geldhoff; Tom van der Poll; Diederik van de Beek
Journal:  Clin Microbiol Rev       Date:  2011-07       Impact factor: 26.132

3.  Acute coronary thrombosis in a patient with septic shock without any evidence of disseminated intravascular coagulation.

Authors:  Imdad Ahmed; William B Nelson; Timinder S Biring; Chad M House; John Marini; Ranjan Dahiya
Journal:  BMJ Case Rep       Date:  2009-08-20

Review 4.  Hemostatic abnormalities in critically ill patients.

Authors:  Marcel Levi; Suthesh Sivapalaratnam
Journal:  Intern Emerg Med       Date:  2014-12-24       Impact factor: 3.397

5.  Pyelonephritis during pregnancy: a cause for an acquired deficiency of protein Z.

Authors:  Jyh Kae Nien; Roberto Romero; Debra Hoppensteadt; Offer Erez; Jimmy Espinoza; Eleazar Soto; Juan Pedro Kusanovic; Francesca Gotsch; Chong Jai Kim; Pooja Mittal; Jawed Fareed; Joaquin Santolaya; Tinnakorn Chaiworapongsa; Samuel Edwin; Beth Pineles; Sonia Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2008-09

6.  Procoagulant and fibrinolytic activity after polytrauma in rat.

Authors:  Xiaowu Wu; Daniel N Darlington; Andrew P Cap
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2015-12-02       Impact factor: 3.619

Review 7.  Systemic versus localized coagulation activation contributing to organ failure in critically ill patients.

Authors:  Marcel Levi; Tom van der Poll; Marcus Schultz
Journal:  Semin Immunopathol       Date:  2011-07-30       Impact factor: 9.623

8.  Growing insights into the potential benefits and risks of activated protein C administration in sepsis: a review of preclinical and clinical studies.

Authors:  Laith Altaweel; Daniel Sweeney; Xizhong Cui; Amisha Barochia; Charles Natanson; Peter Q Eichacker
Journal:  Biologics       Date:  2009-09-15

Review 9.  Recombinant human activated protein C: current insights into its mechanism of action.

Authors:  Marcel Levi; Tom van der Poll
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

Review 10.  COVID-19-Associated Coagulopathy: An Exacerbated Immunothrombosis Response.

Authors:  Apoorva Jayarangaiah; Pramod Theetha Kariyanna; Xiaoyi Chen; Amog Jayarangaiah; Abhishek Kumar
Journal:  Clin Appl Thromb Hemost       Date:  2020 Jan-Dec       Impact factor: 2.389

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.